FDA-cleared clot removal technology, broad indications, addresses a large unmet clinical need in coronary & peripheral applications in a U.S. market of $800M+.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free